TickrTrends AZN fair value analysis

Anthropic Eyes $2 Trillion IPO; AstraZeneca Wins FDA Nod for Breast Cancer Drug

thestockmarketwatch.com · 2026-09-04

AI powerhouse Anthropic is nearing a deal to name Morgan Stanley (MS) as the "lead left" underwriter and Goldman Sachs (GS) as the stabilization

Read the full story at thestockmarketwatch.com →

Is AZN undervalued? See TickrTrends' fair value analysis →